Study Evaluating Pantoprazole in Neonates and Preterm Infants With GERD

Completed · Phase 3

Conditions studied: Gastroesophageal Reflux

In brief

The purpose of this study is to determine whether or not consistent drug levels can be achieved in infants with presumed Gastroesophageal Reflux Disease.

Key facts

Study ID

NCT00362609

Run by

Wyeth is now a wholly owned subsidiary of Pfizer

People needed

59

Starts

2006-07-01

Expected to finish

2007-12-01

Last updated by the study team

2010-05-14

Who can join

Age: 0 and older, up to 0. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Hospitalized patients
• Presumed diagnosis of GERD
• Term or post-term infants within the neonatal period less than 28 days or preterm infants with a corrected gestational age of less than 44 weeks

You may not qualify if…

• cardiovascular instability
• clinically significant laboratory abnormalities
• use of warfarin, carbamazepine, phenytoin, or rifampin

Where it is running

• Study site — Loma Linda, California, United States
• Study site — Oakland, California, United States
• Study site — Orange, California, United States
• Study site — Sacramento, California, United States
• Study site — San Diego, California, United States
• Study site — New Haven, Connecticut, United States
• Study site — Washington D.C., District of Columbia, United States
• Study site — Gainesville, Florida, United States
• Study site — Miami, Florida, United States
• Study site — Sunrise, Florida, United States
• Study site — Atlanta, Georgia, United States
• Study site — Honolulu, Hawaii, United States
• Study site — Boise, Idaho, United States
• Study site — Chicago, Illinois, United States
• Study site — Park Ridge, Illinois, United States
• Study site — Lexington, Kentucky, United States
• Study site — Louisville, Kentucky, United States
• Study site — New Orleans, Louisiana, United States
• Study site — Baltimore, Maryland, United States
• Study site — Boston, Massachusetts, United States
• Study site — Flint, Michigan, United States
• Study site — Omaha, Nebraska, United States
• Study site — Camden, New Jersey, United States
• Study site — New Brunswick, New Jersey, United States
• Study site — Phoenix, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.